Whereas CD45− fractions (ranging from fibroblast-rich to cancer cell-rich samples) were largely conserved between anatomical sites (Fig. 1g), CD45+ fractions (ranging from myeloid-rich to lymphoid-rich samples) were substantially different (Fig. 1f,g and Extended Data Fig. 3c). The gene discussed is PTPRC; the disease is cancer.